Stocks / Pharmaceuticals
ROIVPharmaceuticals
Roivant Sciences Ltd.
$41.231d +16.8%5d +17.2%settled close · 2026-09-08
Mkt cap $19B (9/8)β 1.0952w $27–41Shares 715.7MInd. Pharmaceutical PreparationsNasdaq since 2021Emp. 750HQ Londonroivant.com
Who’s talkingIdea Scout · free
Who’s talking about ROIV
No tracked investor commentary on ROIV yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where ROIV’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 9 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-08 | ||||||
| 2026-08-19 | ||||||
| 2026-08-17 | ||||||
| 2026-08-14 | ||||||
| 2026-08-06 | ||||||
| 2026-06-29 | ||||||
| 2026-06-24 | ||||||
| 2026-06-17 | ||||||
| 2026-05-20 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
ROIV is in this morning’s Brief.
Get The Brief — $20/mo →